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Leaf samples of Euclea crispa subsp. crispa were col-
lected in the Bloemfontein area of the Free State
Province as part of a project to screen South African
plants for their antimicrobial potential. Crude extracts
were obtained with a 95% methanol solution and the
aqueous fraction remaining after methanol was
removed by distillation, was bioassayed in vitro for its
potential to inhibit the growth of eleven human patho-
genic bacteria and two human pathogenic fungi. Of all
the plant extracts tested, the E. crispa crude leaf extract
showed the most promising antimicrobial activity
against human pathogenic bacteria and fungi.
Subsequently, the crude extract was fractionated by
means of liquid-liquid extraction using four different
organic solvents in order of increasing polarity. Most of
the antibacterial activity was observed in the more polar
ethyl acetate fraction. No particular trend of inhibition
was observed between the Gram-negative and Gram-
positive bacteria. Neither the crude extract nor the semi-
purified fractions inhibited the growth of Haemophilus
influenzae, Klebsiella pneumoniae and Streptococcus
pneumoniae. The growth of the other eight human path-
ogenic bacteria was inhibited to different degrees. Both
the crude extract as well as all the semi-purified frac-
tions inhibited the growth of two human pathogenic test
fungi.
Throughout the history of mankind, many infectious dis-
eases have been treated with plant extracts. These are still
used extensively today for primary health care in developing
countries where traditional medicine plays a major role (Irobi
and Daramola 1993, Farnsworth 1994, Shale et al. 1999,
Sokmen et al. 1999). Due to many rural people still relying
on cheaper traditional healing methods, despite the avail-
ability of Western medicine, it is estimated that between 12
and 15 million South Africans still use traditional remedies
from as many as 700 indigenous plant species (Grierson
and Afolayan 1999).
Plants are still the almost exclusive source of drugs for the
majority of the world’s population and major pharmaceutical
companies have also shown renewed interest in higher
plants as a source of possible novel active substances
(Hamburger and Hostettmann 1991). Moreover, treatment
with immunosuppressive drugs and the spread of AIDS have
lead to diseases, caused by weaknesses in the human
immune system, to become more and more prevalent.
Infections commonly observed in the immuno-compromised
host include candidiasis and cryptococcosis as well as
aspergillosis (Hostettmann and Marston 1994). Other dis-
eases are respiratory, e.g. streptococcal, staphylococcal
and infections by Haemophilus influenzae, while yet other
systemic infections are caused by Streptococcus pneumoni-
ae, Streptococcus pyogenes and Neisseria meningitidis,
among pathogenic bacteria (Brock and Madigan 1991).
During a preliminary screen of crude extracts from 26
plant species growing in the Free State Province of South
Africa, using the sensitive Gram-negative bacterium
Branhamella catharralis as test organism, the crude extract
of E. crispa (Thunb.) Guerke subsp. crispa (Ebenaceae) was
identified as one of the most promising. Subsequently, a
comprehensive study was undertaken with this extract.
E. crispa subsp. crispa is known as one of the most com-
mon trees in South Africa (Venter 1976, Malan et al. 1998).
Although Euclea species are extensively utilised in tradition-
al medicine for a wide range of ailments, including gonor-
rhoea, wounds, leprosy, scabies and dysentery (Khan and
Rwekika 1992), E. crispa subsp. crispa is, ironically, the
least documented of the subspecies in terms of its applica-
tion potential. An infusion of the root bark is used as a cough
remedy as well as for the treatment of measles and
melanomas (Sibanda et al. 1992) but, the active substances
involved in the treatment of these diseases are not known.
No mention has been made in the past of any use for the
leaves.
Phytochemical analysis of E. crispa and a few other
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species belonging to the family Ebenaceae have been
attempted in the past (Costa et al. 1976, Khan and Rwekika
1992, Sibanda et al. 1992). Pentacyclic triterpenoids, lupeol,
betulin and oleanolic acid were isolated from the root bark of
E. crispa (Sibanda et al. 1992) while Hutchings et al. (1996)
reported that roots of Euclea species as well as leaves of
other species from the family Ebenaceae have been found
to be rich in naphthaquinones. Dark coloured naph-
thaquinones, or their derivatives, are commonly produced in
leaves of Euclea species and 27 naphthaquinone deriva-
tives have been isolated from plants belonging to the family
Ebenaceae (Hutchings et al. 1996). Other compounds iso-
lated from species in this family include phytosterols and ter-
penoids (Sibanda et al. 1992). However, which of these sec-
ondary metabolites possess antibacterial properties remains
to be shown.
In this paper we report on the antimicrobial properties of
crude and semi-purified extracts from leaves of E. crispa
subsp. crispa. This investigation served as an initial guide
towards the isolation of the active compounds.
Materials and Methods
Plant material
Plant leaf material was collected in the Bloemfontein area of
the Free State Province, South Africa, during the summer of
March 1998. The plant was identified and authenticated by
Dr PC Zietsman from the National Museum in Bloemfontein
and a voucher specimen was deposited in the museum’s
herbarium under the number NMB20483.
Other materials and chemicals
All the chemicals used for the preparation of crude or semi-
purified extracts were purchased from Merck (Germany) and
were of the purest grade available. Müller-Hinton (MHA) and
Sabouraud agar were supplied by Sigma (Germany) and
nutrient broth was a product from Biolab. Ampicillin, chlo-
ramphenicol and penicillin were purchased from the Weil
Organisation, South Africa.
Preparation of a crude extract 
A crude extract was prepared by performing ten extractions
on 1.73kg of powdered material with 95% (v/v) methanol in
water at a ratio of 2ml g-1 powdered plant material, at room
temperature, by using a mechanical shaker. Ten extractions
were carried out, by shaking each for 15min, while new sol-
vent was used for each extraction. The ten extraction frac-
tions were combined, filtered through Whatman No. 1 filter
paper under vacuum using a Büchner funnel and evaporat-
ed under vacuum by means of a Büchi Rotary Evaporator at
temperatures below 40°C to leave a methanol-free extract.
The remaining aqueous solution, referred to as the crude
extract, was found to give higher yields of active compounds
with subsequent liquid-liquid extraction than did crude
extracts obtained with either 100% methanol or acetone. For
this reason extraction with 95% methanol was adopted as
standard procedure. The aqueous crude extract was cen-
trifuged at 12 000 x g at room temperature for 10min and the
concentration determined in triplicate by drying 1ml aliquots
in an oven at 80°C to a constant weight (Brownleader and
Dey 1997). Before screening the supernatant (Ganesan and
Krishnaraju 1995) for antimicrobial activity, the appropriate
concentration was obtained by diluting with a 10% (v/v) solu-
tion of dimethyl sulphoxide (DMSO) in water. Extracts were
stored at -20°C (Bloor 1995).
Preparation of semi-purified extracts 
Semi-purified extracts were prepared by fractionating the
aqueous crude extract by means of liquid-liquid extraction
using the following solvents in a volume ratio of 2ml solvent
ml-1 aqueous crude extract and in order of increasing polar-
ity: n-hexane (DC = 2.0), diethyl ether (DC = 4.3), chloroform
(DC = 4.8) and ethyl acetate (DC = 6.0, Harwood and Moody
1989). Fractionation with each solvent was repeated ten
times by shaking vigorously on a mechanical shaker for
10min. The four solvent extractives were collected sepa-
rately and subsequently evaporated to dryness under vacu-
um at 35°C or below, depending on the solvent being
removed, using a Büchi Rotary Evaporator. Each fraction
was tested separately for antimicrobial activity.
Screening for antimicrobial activity of extracts towards
human pathogens
Human pathogenic bacteria and fungi were clinical isolates
provided by the Department of Medical Microbiology, Faculty
of Health Sciences, University of the Free State. Bacteria
included Acinetobacter baumannii, Bacillus subtilis,
Escherichia coli, Haemophilus influenzae, Klebsiella pneu-
moniae, Branhamella catarrhalis, Pseudomonas aerugi-
nosa, Staphylococcus aureus, Staphylococcus epidermidis,
Streptococcus pneumoniae and Streptococcus pyogenes
while human pathogenic fungi were Candida albicans and
Cryptococcus neoformans.
A modified agar diffusion method (Rios et al. 1988) was
used for screening both crude and semi-purified extracts for
antibacterial and antifungal activity. This method is widely
used for antibiotic susceptibility testing as well as for screen-
ing possible medicinal plants (Kavanagh 1975, Gordon et al.
1980, El-Abyad et al. 1990, Irobi and Daramola 1993). To
obtain the desired test concentration of 1mg ml-1, the dried
crude extract, chloroform and ethyl acetate fractions were
dissolved in a 10% (v/v) solution of DMSO in water, while the
less polar hexane and diethyl ether extractives were dis-
solved in a 10% (v/v) solution of Tween-80 in water. All
experiments were repeated twice and every extract was
tested in duplicate. At the end of the incubation period, inhi-
bition zones were measured with a transparent ruler on two
axes at right angles to each other to give two readings from
each test. The measurement included the assay hole (March
et al. 1991, Pfaller et al. 1992).
Antibacterial tests
Müller-Hinton (MHA) agar was prepared according to the
manufacturer’s specifications, autoclaved for 20min at
195
121°C and cooled to 45°C in a waterbath. On cooling, the
agar was aseptically poured into disposable plastic petri
dishes of 9mm diameter to a thickness of 2–3mm and
allowed to solidify in a laminar flow cabinet. Modifications
were made depending on the nutritional demands of the dif-
ferent organisms. In the case of Streptococcus pneumoniae
and Streptococcus pyogenes, sheep blood was added to the
MHA (Caceres et al. 1991).
Stock cultures of human pathogenic bacteria were main-
tained on nutrient agar slants (Biolab) at 4°C and prepared
for antibacterial tests by growing in nutrient broth (Biolab) for
24h at 37°C. Overnight cultures were diluted 1:100 with
fresh sterile MHA broth to obtain 106cfu ml-1 (Meyer and
Afolayan 1995). The bacterial suspension was streaked
evenly on the agar plates with a sterile cotton bud. Holes of
6mm in diameter were made in the agar and in the centre of
each test plate by means of a sterile cork borer. 50μl crude
extract or semi-purified fraction was transferred to the holes
in the agar representing 50μg of extract per hole. After equi-
libration at room temperature (Van den Berghe and Vlietinck
1991), the plates were incubated for 24h at 37°C in the dark.
In the case of non-aerobes, a carbon dioxide atmosphere
was created by a continuous flow of the gas into the incuba-
tion chamber.
Three types of negative controls were used namely 50μl
of each of a 10% (v/v) solution of DMSO in water, 10% (v/v)
solution of Tween-80 in water and pure distilled water. The
positive controls were different antibiotic standards for differ-
ent organisms and included ampicillin (10μg disk-1), chlo-
ramphenicol (30μg disk-1) and penicillin (10 units).
Antifungal tests with human pathogens
The same protocol as for bacteria was followed except that
Sabouraud agar was used to which 300μl of a 10% (m/v)
chloramphenicol solution was added to control bacterial
growth. Stock cultures of human pathogenic fungi were
stored on Sabouraud dextrose agar slants at 4°C (Irobi and
Daramola 1993). An overnight growth of a freshly prepared
mother culture for each pathogen was diluted 1:100 with the
same fresh sterile broth. This was evenly spread on a ster-
ile Sabouraud agar plate, for each pathogen separately, with
a sterile cotton bud. Holes of 10mm diameter were made on
the agar surface with a sterile cork borer. After 50μl of the
crude extract or semi-purified fractions were transferred into
the holes in the agar, it was allowed to diffuse into the agar
for 1h at room temperature and subsequently incubated at
37°C for 48h (Verastegui et al. 1996). Negative controls
were unseeded agar plates, agar plates seeded with 50μl of
a 10% (v/v) Tween-80 solution in water and agar plates
seeded with 50μl of a 10% (v/v) DMSO solution in water. The
positive control was nystatin (Difco, 30μg disk-1). Each test
was repeated in triplicate.
Results
The results in Table 1 show that where there was inhibition
of growth of the human pathogenic bacteria, all the meas-
ured zones of inhibition were significant, i.e. >10mm (Naqvi
et al. 1991). From the 11 bacteria used, an inhibition sensi-
tivity pattern emerged separating the organisms into five
groups. Belonging to the first group were two Gram-negative
bacteria totally resistant to inhibition by the crude extract and
all of the semi-purified fractions, namely H. influenzae and
K. pneumoniae. The second group of three Gram-positive
bacteria, B. subtilis, S. aureus and S. epidermidis, were
sensitive to inhibition by the crude extract and only the ethyl
acetate fraction. A. boumanii and E. coli, both Gram-nega-
tive, that were sensitive to inhibition by the ethyl acetate
fraction only, formed the third group. Those bacteria sensi-
tive to inhibition by the crude extract and all of the semi-puri-
fied fractions formed the fourth group and included B.
catharralis and P. aeruginosa, both Gram-negative. The fifth
group included those bacteria sensitive to inhibition by the
hexane, diethyl ether and chloroform fractions but neither
the crude extract nor the ethyl acetate fraction. S. pneumo-
niae and S. pyogenes, both Gram-positive bacteria,
belonged to the last group.
The ethyl acetate fraction gave the largest zones of inhibi-
tion and showed the broadest spectrum of activity by inhibit-
ing the growth of seven of the eleven (64% of test organ-
isms) human pathogenic bacteria, compared to only the five
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Table 1: Antibacterial activity of a crude extract and semi-purified liquid-liquid extractions of Euclea crispa subsp. crispa against human path-
ogenic bacteria at a concentration of 1mg ml-1
Bacteria Mean inhibition zone diameter (mm)
(Gram -ve or Gram -ve) Crude extract Hexane Diethyl ether Chloroform Ethyl acetate Antibiotic control
A. baumanni (-) 0 0 0 0 11.0 ± 0.7 17.0 ± 0.0 a
B. subtilis (+) 12.0 ± 0.4 0 0 0 15.0 ± 0.4 35.0 ± 0.4 b
E. coli (-) 0 0 0 0 12.0 ± 0.4 18.0 ± 0.4 b
H. influenzae (-) 0 0 0 0 0 29.0 ± 0.4 b
K. pneumoniae (-) 0 0 0 0 0 33.0 ± 0.6 b
M. catharralis (-) 27.0 ± 0.8 20.0 ± 0.4 25.0 ± 0.6 20.0 ± 0.8 34.0 ± 0.6 18.0 ± 0.6 a
P. aeruginosa (-) 14.0 ± 0.6 13.0 ± 0.8 13.0 ± 0.8 20.0 ± 0.8 21.0± 0.4 32.0 ± 0.0 b
S. aureus (+) 16.0 ± 0.6 0 0 0 25.0 ± 0.4 32.0 ± 0.4 b
S. epidermidis (+) 18.0 ± 0.4 0 0 0 24.0 ± 0.4 33.0 ± 0.0 b
S. pneumoniae (+) 0 19.0 ± 0.4 17.0 ± 0.0 22.0 ± 0.8 0 21.0 ± 0.6 b
S. pyogenes (+) 0 13.0 ± 0.0 14.0 ± 0.4 12.0 ± 0.8 0 28.0 ± 0.4 c
a Ampicillin (10μg disk-1); b Chloramphenicol (30μg disk-1); c Penicillin (10 units)
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(45% of test organisms) inhibited by the crude extract. The
single bacterium most sensitive to inhibition by E. crispa
extracts, B. catharralis, as well as the two most resistant
ones, H. influenzae and K. pneumoniae, were all Gram-neg-
ative bacteria. However, no particular trend was observed
regarding the inhibition by E. crispa extracts of Gram-nega-
tive and Gram-positive bacteria except that where bacteria
grouped together they were always of the same type regard-
less of what group they belonged to.
All the extracts, with the exception of the hexane fraction,
inhibited the growth of both human pathogenic fungi (Table
2). The largest zones of inhibition were obtained with the
crude extract and Candida albicans seemed slightly more
sensitive to inhibition than Cryptococcus neoformans as
indicated by larger inhibition zones. Of the semi-purified
fractions, slightly larger inhibition zones were obtained with
ethyl acetate in the case of both pathogens, albeit signifi-
cantly less than that obtained with the crude extract.
Discussion
Depending on the extraction procedure, one would expect
that a crude plant extract would contain all the possible
antimicrobial active substances in the plant and that screen-
ing of the crude extract would be the only method needed to
evaluate the potential of a medicinal plant in this regard.
However, the crude extract of E. crispa subsp. crispa inhib-
ited the growth of only five of the eleven human pathogenic
bacteria while either the ethyl acetate or the other three
semi-purified fractions inhibited the growth of four additional
bacteria towards which the crude extract showed no activity,
indicating a possible concentration effect.
A number of authors (Caceres et al. 1993, Desta 1993,
Ekpendu et al. 1994) have compared the activities of crude
extracts prepared with solvents of different polarities and
noted different inhibition trends among test organisms. The
patterns of inhibition varied between test organisms, proba-
bly due to differences in sensitivity to different phytochemi-
cals, but also from solvent to solvent due to differences in
polarity and the ability to extract specific phytochemicals
(Kwo et al. 1996, Iqbal et al. 1998). However, in general,
crude extracts obtained by extracting plant material with
methanol proved to be more successful in terms of the vari-
ety of phytochemicals removed than with either water or
other organic solvents (Borris 1996).
The aqueous crude E. crispa extract, prepared with 95%
(v/v) methanol in this study, contained all of the phytochem-
icals later fractionated into solvents of different polarities, but
no activity could be detected in the case of six of the eleven
test bacteria when treated with the crude extract only. As the
concentrations used to screen the crude extract and the
semi-purified fractions for its antibacterial potential were the
same, this indicated that the concentration of a specific
active substance(s) was probably too low in the crude
extract due to a dilution effect by the presence of other phy-
tochemicals. This shows that valuable information may be
lost when screening with crude extracts only and that this
practice should be treated with caution.
The liquid-liquid extraction of the crude extract with the
low polarity solvent, hexane (DC = 2.0), was mainly to
remove chlorophylls and lipids. Chloroform (DC = 4.8) was
used merely to ascertain whether all substances soluble in
diethyl ether (DC = 4.3) had been removed as the polarity of
these two solvents is very close. Hence, not much activity
was expected from the chloroform fraction. However, anti-
bacterial activity was indeed detected in this fraction indicat-
ing that either the small difference in DC-values between
diethyl ether and chloroform was sufficient to distinguish
between phytochemicals differing only slightly in polarity, or
that fractionation with diethyl ether was not complete. Ethyl
acetate (DC = 6.0) extracted substances of higher polarity
than the first three solvents and, of the four extracts, the
ethyl acetate fraction seemed to possess most of the anti-
bacterial active substances as indicated by both inhibition
zone diameter size and the broad spectrum of control.
It is, however, interesting to note that inhibition of human
pathogenic bacteria by the three less polar fractions hexane,
diethyl ether and chloroform were identical in the sense that
they were all either active or totally inactive against a specif-
ic organism. On the other hand, the growth of five test bac-
teria was not inhibited by either of the three less polar frac-
tions but indeed by the ethyl acetate fraction, indicating a dif-
ference in sensitivity to different phytochemicals amongst
organisms.
The crude extract and all of the semi-purified fractions
except the hexane fraction inhibited the growth of the two
human pathogenic test fungi, Candida albicans and
Cryptococcus neoformans. This indicated that the different
solvents, probably on the basis of differences in polarity,
fractionated different antifungal compounds. The largest
inhibition zones were obtained with the most polar of the
extracts namely the crude extract and the ethyl acetate frac-
tion. The similar zones of inhibition observed for the diethyl
ether and chloroform fractions as well as the fact that most
of the essential oils were detected in these two fractions
(results not shown) confirm that these solvents extracted
similar antifungal compounds.
The larger inhibition zones obtained with the ethyl acetate
fraction for human pathogenic bacteria and the crude extract
for fungi, imply that both the antibacterial and antifungal
active substances in E. crispa are rather polar. As the crude
extract and all of the semi-purified fractions were mixtures of
compounds, the large inhibition zones may have been the
result of either highly active substances present in small
amounts or by substances of low activity present in high
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Table 2: Antifungal activity of a crude extract and semi-purified liq-
uid-liquid extractions of Euclea crispa subsp. crispa against human
pathogenic fungi at a concentration of 1mg ml-1
Extraction or fraction Mean inhibition zone diameter (mm)
Candida albicans Cryptococcus neoformans
Crude 25.0 ± 0.4 20.0 ± 0.6
Hexane 0 0
Diethyl ether 14.0 ± 0.4 12.0 ± 0.0
Chloroform 15.0 ± 0.4 12.0 ± 0.4
Ethyl acetate 18.0 ± 0.8 15.0 ± 0.8
Control* 33.0 ± 0.4 30.0 ± 0.6
* Nystatin (100 units, Difco) antibiotic control
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concentrations (Van den Berghe and Vlietinck 1991).
Moreover, antibacterial agents may exert different effects on
the structure and functioning of bacterial cells, with the
important targets of chemotherapeutic action being the cell
wall, cell membrane and the processes of protein and nucle-
ic acid synthesis (Brock and Madigan 1991). This can
explain the differences in sensitivity to the different extracts.
The results presented in this paper confirmed that the
leaves of E. crispa subsp. crispa contain antimicrobial com-
pounds of which most are extracted by more polar solvents.
The use of extracts from Euclea species by the local popu-
lation for the treatment of ailments are usually in the form of
infusions, decoctions and tinctures (Van Wyk et al. 1997),
which are quite polar themselves. The concentrations of the
extracts required to inhibit the growth of test microorganisms
in this study seem to be high in comparison with those of
antibiotics normally used (and DDAC). It should neverthe-
less be considered, that crude and semi-purified extracts
were screened in this study and the compounds responsible
for the antimicrobial activity are obviously metabolites nor-
mally found in small quantities (Onah et al. 1994, Zavala et
al. 1997). This low activity in comparison with the antibiotics
(and DDAC) might also have been due to weakly active
compounds present in substantial concentrations.
The variations in activity towards the test bacteria may
have been due to different phytochemicals in different frac-
tions and/or different diffusion dynamics in the agar.
Moreover, permeability barriers peculiar to each of the four
isolates from E. crispa subsp. crispa and also to the nature
of the individual bacterial species that determines their sen-
sitivity to the extracts may also have determined the differ-
ences in activity measured. Impermeability to drugs or
chemical substances can confer resistance on microorgan-
isms (Onah et al. 1994).
The crude and ethyl acetate fractions, being more polar,
contained antimicrobial compounds that were significantly
active towards the plant pathogenic bacteria. This implies
that the 95% solution of methanol in water and the ethyl
acetate extracted most of this antibacterial activity from E.
crispa subsp. crispa. In the case of human pathogenic bac-
teria, all of the five fractions showed some activity towards
the pathogens. This could be due to the different nature of
each species and hence the site of inhibition of each. On the
other hand, compounds with activity towards human patho-
genic fungi (C. albicans and C. neoformans) were extracted
with the solvents diethyl ether, chloroform and ethyl acetate.
Most of the activity, though, was extracted by the solvent
ethyl acetate.
E. crispa subsp. crispa seems to be a good source of
antimicrobials for the treatment of both bacterial and fungal
infections. The results of this investigation confirmed its use
in traditional medicine. Literature mentioning the use of this
plant against plant pathogens was not found though our
results show effective antibacterial activity against plant
pathogenic bacteria in the crude and the ethyl acetate frac-
tions (results not shown). Because of the localisation of most
of the antimicrobial activity in the ethyl acetate fraction, we
are currently attempting to isolate and purify compounds
with antimicrobial activity from this fraction with the aim of
identifying the active substances.
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